Bottom line
Is AIBD a good fund? The bottom line
AIBD is an actively managed leveraged & inverse ETF from Direxion.
Its expense ratio is 1.05% — about $105 a year on every $10,000 invested, cheaper than 66% of leveraged & inverse funds we track.
It returned −48.9% over one year (as of Dec 31, 2025, per its prospectus).
With $7.4 million in net assets and 7 holdings, its largest position is Dreyfus (57.2%) and the top 10 make up 112.1% of the portfolio.
What to watch
- Concentrated: top 10 holdings are 112.1% of assets
- Small fund ($7.4 million) — small funds are likelier to close
Updated Nov 19, 2026
What AIBD invests in
The Fund seeks daily investment results, before fees and expenses, of 200% of the inverse (or opposite) of the daily performance of the Index. The Fund does not seek to achieve its stated investment objective for a period of time different than a trading day.
"The Index is designed by Solactive AG (the Index Provider) to represent the securities of companies from the United States that have business operations in the field of artificial intelligence (AI) applications and big data. The Index includes U.S. listed securities with certain minimum capitalization and liquidity requirements that the Index Provider defines as AI and big data companies using the following criteria: The Index Provider uses ARTIS , its proprietary natural language processing algorithm, to identify and rank AI and big data companies for inclusion in the Index. ARTIS uses keywords to review large volumes of publicly available data, such as company annual reports, published business descriptions, and financial news reports, which the Index Provider believes will identify and classify companies as being in the field of AI and big data, and then ranks the companies based…
From the fund's prospectus (filed Mar 3, 2026).
AIBD performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| AIBD | −48.9% | — | — |
| Leveraged & Inverse median | −7.7% | −11.8% | −13.5% |
Source: Fund prospectus, as of Dec 31, 2025
What AIBD costs
On a $10,000 investment, AIBD's 1.05% expense ratio costs about $105 a year. The prospectus estimates $2,855 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.
AIBD top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dreyfus | 57.21% |
| 2 | Dreyfus | 22.25% |
| 3 | Goldman Sachs Liq Es Fd A | 16.92% |
| 4 | Goldman Financial | 12.18% |
| 5 | N/a | 2.92% |
| 6 | N/a | 2.81% |
| 7 | N/a | -2.18% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 112.1% of the fund. See all top 25 holdings and asset mix →